All Stories

  1. Understanding the lived experience of epilepsy through creative engagement workshops: Insights beyond patient-generated questions
  2. New headache guidance shifts the queue, not the outcomes
  3. Transfer learning enhances clinical utility of polygenic scores with small, phenotypically refined cohorts
  4. Is it time for the removal of valproate restrictions in men? Further evidence from a new study
  5. Mind the Gap! What do people with epilepsy want to know?
  6. Vivid Dreams and Nightmares as an Adverse Effect of Beta‐Blockers in the Treatment of Episodic Migraine
  7. Incomplete T-cell tolerance and epitope-specific responses to the NR1 subunit in NMDA receptor antibody-associated encephalitis
  8. ‘How to do it…. The epilepsy follow-up visit’
  9. Neuropsychiatric research databases for people with intellectual disabilities and epilepsy (REFINE): a feasibility study protocol
  10. Frontal lobe epilepsy- why it matters in the emergency department
  11. Is intravenous aciclovir overused in possible viral encephalitis? a retrospective review
  12. Defining the typical characteristics of orthostatic headache in patients with spontaneous intracranial hypotension
  13. The patient voice: valproate, topiramate and MHRA regulation
  14. New valproate regulations, informed choice and seizure risk
  15. Imágenes en Neurología Clínica
  16. SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy
  17. Epilepsy update: diagnosis, classification and management
  18. Awareness of social care needs in people with epilepsy and intellectual disability
  19. Teaching NeuroImage: Cerebellar Atrophy Due to JC Virus Granule Cell Neuronopathy
  20. Migraine prevention: initial treatment options
  21. Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension
  22. Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case–control study
  23. Deep phenotyping of frontal lobe epilepsy compared to other epilepsy syndromes
  24. Tackling increased risks in older adults with intellectual disability and epilepsy: Data from a national multicentre cohort study
  25. Antiseizure medications (antiepileptic drugs) in adults: starting, monitoring and stopping
  26. Mind the Gap! Developing Patient Responsive Information for Epilepsy
  27. Migraine in people with epilepsy: a treatable and neglected co-morbidity
  28. Deep phenotyping of frontal lobe epilepsy compared to other epilepsy syndromes
  29. Confidence College – an online education tool for neurology patients
  30. Increasing incidence of autism spectrum disorder: are we over-diagnosing?
  31. Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study
  32. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study
  33. Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study
  34. Idiopathic Intracranial Hypertension in Transgender People: Case Report and Best Practice
  35. Navigating migraine care through the COVID-19 pandemic: an update
  36. Adult occipital lobe epilepsy: 12-years on
  37. Whole genome sequencing for diagnosis of neurological repeat expansion disorders
  38. Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour – Everyone’s business, no one’s priority
  39. Valproate prescribing practices for women with intellectual disability across Europe
  40. Tics induced by antiepileptic drugs: a pragmatic review
  41. Epilepsy: diagnosis, classification and management
  42. Reply to Calabrò: Towards a better understanding of valproate induced sexual and reproductive dysfunction in men with epilepsy
  43. The Epilepsy Risk Awareness (ERA) Scale: A New Era for Holistic Risk Assessment in Epilepsy
  44. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial
  45. Psychological and demographic characteristics of 368 patients with dissociative seizures: data from the CODES cohort
  46. Manual acupuncture for migraine
  47. Valproate risk form—Surveying 215 clinicians involving 4775 encounters
  48. My dad and progressive supranuclear palsy (PSP)
  49. Valproate, sexual health, and men: A narrative review
  50. Out of sight: a lesson in drug errors
  51. Treatment decisions in women of childbearing age on valproate
  52. Characteristics of 698 patients with dissociative seizures: A UK multicenter study
  53. Dealer’s Dytonia (Croupier’s Cramp) – An Unusual Hazard Of Gambling
  54. Valproate and the Pregnancy Prevention Programme: exceptional circumstances
  55. Valproate MHRA Guidance: Limitations and Opportunities
  56. Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid
  57. Valproate, women, and exceptional circumstances
  58. Focal epilepsy as a late complication of congenital dacryocystocele
  59. as well as sudden thunderclap headaches during sex, migraine aura can occur during sex
  60. Weighing the risks of valproate in women who could become pregnant
  61. The provision of care to adults with an intellectual disability in the UK. A Special report from the intellectual disability UK chapter ILAE
  62. Abdominal migraine
  63. PO063 Utility of mri in central and peripheral neuropathic pain (np)
  64. Third cranial nerve palsy: an unusual manifestation of Mycoplasma pneumoniae
  65. Langerhans cell histiocytosis (eosinophilic granuloma) of the skull mimicking nummular headache. Report of two cases
  66. Development of the Epilepsy Risk Awareness scale (ERA scale) for people with epilepsy
  67. Epilepsy Risk Awareness Scale
  68. Discussing sudden unexpected death in epilepsy: Are we empowering our patients? A questionnaire survey
  69. Familial limb pain and Migraine
  70. WHO analgesic ladder and chronic pain: the need to search for treatable causes
  71. DISCUSSING SUDDEN UNEXPECTED DEATH IN EPILEPSY: ARE WE EMPOWERING OUR PATIENTS?
  72. FAMILIAL MIGRAINE LIMB PAIN SYNDROME (MLPS): THREE GENERATIONS AND SEVEN YEAR FOLLOW-UP
  73. Familial limb pain and migraine: four generations and eight year follow-up
  74. Sudden unexpected death in epilepsy: improving our discussions with patients
  75. Author's reply to Girling
  76. Author's reply to McKinley
  77. First seizures in adults
  78. First seizures in adults
  79. Creutzfeld-Jakob Disease—Reply
  80. Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy
  81. Migraine: mimics, borderlands and chameleons
  82. Length of Carotid Stenosis Predicts Peri-Procedural Stroke or Death and Restenosis in Patients Randomized to Endovascular Treatment or Endarterectomy
  83. Autoantibodies in Sporadic Creutzfeldt-Jakob Disease
  84. Hepatic encephalopathy with epilepsia partialis continua: A case report
  85. Syncope and Raynaud’s Disease
  86. We must warn women about the risks of untreated, or ineffectively treated, epilepsy
  87. 042 A critical analysis of studies of antiepileptic drugs (AEDs) and pregnancy. Maternal safety is neglected
  88. 041 The use of prolonged EEG recording in the diagnosis and clinical management of epilepsy
  89. PO.09 Syncope and Raynaud's disease
  90. A pilot study of the epilepsy risk awareness checklist (ERAC) in people with epilepsy and learning disabilities
  91. Epilepsy Risk Awareness Checklist
  92. A new era in acute neurological consultations
  93. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial
  94. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial
  95. Epilepsy management
  96. Epilepsy: epidemiology, classification and natural history
  97. Diagnosing epilepsy in neurology clinics: A prospective study
  98. Seizures and adverse events during routine scalp electroencephalography: A clinical and EEG analysis of 1000 records
  99. Restenosis After Carotid Angioplasty, Stenting, or Endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS)
  100. HEADACHE AND MIGRAINE IN CHILDHOOD AND ADOLESCENCE
  101. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial
  102. Headache: Basic Trial Designs, Sample Sizes and Pitfalls
  103. HANDBOOK OF HEADACHE MANAGEMENT: A PRACTICAL GUIDE TO DIAGNOSIS AND TREATMENT OF HEAD, NECK AND FACIAL PAIN.
  104. Convergence of Occipital Nerve and Superior Sagittal Sinus input in the Cervical Spinal Cord of the Cat
  105. Convergence of Afferents from Superior Sagittal Sinus and Tooth Pulp on Cells in the Thalamus of The Cat
  106. Convergence of afferents from superior sagittal sinus and tooth pulp on cells in the upper cervical spinal cord of the cat
  107. Book reviews
  108. Experimental and Clinical Pharmacology: Dopamine - clinical applications i. neurology
  109. The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids
  110. Craniovascular nociceptive pathways relay in the upper cervical spinal cord in the cat
  111. The function of large and small nerve fibers in renal failure
  112. Pseudodementia twelve years on.
  113. Convergence of afferents from superior sagittal sinus and tooth pulp on cells in the upper cervical spinal cord or in the thalamus of the cat
  114. The Cervical Spinal Cord is a Relay Centre for the Central Nervous System Processing of Input from the Cranial Vasculature
  115. The law and a physically‐ill patient with anorexia nervosa: liberty versus paternalism